Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis

D. Wolf, G. D'Haens, W. J. Sandborn, J. F. Colombel, G. Van Assche, A. M. Robinson, A. Lazar, Q. Zhou, J. Petersson, R. B. Thakkar

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Escalation to weekly dosing recaptures response in adalimumab-treated patients with moderately to severely active ulcerative colitis'. Together they form a unique fingerprint.

Medicine & Life Sciences